noted between OAR and EVAR (11.7% vs 12.3%; P ¼ .59). After adjusting for potential confounders, FTR was not significantly different in OAR compared to EVAR (adjusted odds ratio [aOR], 1.34; 95% confidence interval [CI], 0.94-1.91; P ¼ .10). Factors impacting in-hospital FTR included older age (aOR, 1.05; 95% CI, 1.03-1.07; P < .001), prior failed open repair (aOR, 8.17; 95% CI,; P < .001), and a history of chronic obstructive pulmonary disease (aOR, 1.53; 95% CI, 1.08-2.15; P ¼ .02; Table II) . A similar analysis of 2916 patients with postdischarge complications showed that FTR in those patients was significantly higher in OAR compared to EVAR (aOR, 4.75; 95% CI, 2.45-9.25; P < .001).
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Differences in Endovascular Aortic Aneurysm Repair (EVAR) Presentation and Outcomes Based on Method of Aneurysm Discovery
William E. Beckerman, Ajit Rao, Daniel K. Han, Sean P. Wengerter, Melissa Baldwin, Rami O. Tadros, Michael Marin, Peter Faries. Icahn School of Medicine at Mount Sinai, New York, NY Objectives: Ultrasound screening identifies patients at high risk for abdominal aortic aneurysms (AAA), but there exists limited data regarding how AAAs necessitating treatment with endovascular aneurysm repair (EVAR) initially present. This study aimed to evaluate how AAAs requiring EVAR are discovered as well as differences in presentation and outcome based on method of discovery.
Methods: A retrospective analysis of a prospectively maintained database at a single health system was performed for all patients undergoing EVAR. Patients with a recorded method of AAA discovery were identified and categorized as incidental, symptomatic, screened by ultrasound, or found on physical examination. Demographics, comorbidities, maximum AAA diameter at time of discovery, time of treatment with EVAR, and postoperative outcomes were identified and compared.
Results: Of 232 patients identified as meeting inclusion criteria, most AAAs were discovered incidentally (180 [77.6%]) with far fewer discovered by ultrasound screening (27 [11.6%]), physical examination (20 [8.6%]), or symptomatically (5 [2.2%]). Symptomatic AAAs were larger on discovery (60.3 mm vs 43.9 mm; P ¼ .034) compared with asymptomatic AAAs. Patient demographics and comorbidities based on method of discovery were comparable, although symptomatic patients were more likely to be female (60% vs 22.5%; P ¼ .034). Notably, only 35.6% of patients with incidentally discovered AAA met Medicare's one-time ultrasound screening guidelines. Symptomatic AAA patients had more intraoperative complications (40% vs 10.7%; P ¼ .039), required more perioperative transfusions (40% vs 5.6%; P ¼ .002), and had longer lengths of stay (5.2 vs 1.5 days; P < .001). Incidentally found AAA patients had fewer intraoperative complications (8.9% vs 10.7%; P ¼ .037). Rates of endoleak, reintervention, and AAA-related mortality were not different between the study groups.
Conclusions: Most AAA patients requiring EVAR are discovered incidentally. More awareness and compliance with Medicare's screening guidelines for AAA is vital because a sizeable percentage of incidentally discovered AAA patients were candidates for one-time screening ultrasounds. Finally, as many studied patients requiring EVAR fell outside Medicare's guidelines, this study supports liberalizing and individualizing the decision to screen patients at risk of AAA. Objectives: Aortic dissection (AD) is an uncommon event associated with a 25% to 30% mortality rate. AD is easily identified on computed tomography angiography (CTA); however, specific morphologic features are not well characterized. This study evaluated CTA images in patients with and without AD to identify specific morphologic features consistently seen following AD.
Methods: Between 2004 and 2016, patients with type B AD were screened by International Classification of Diseases codes. Patients who had >5-year follow-up imaging results without repair were selected for evaluation. Over the same time period, a matched cohort of control patients who underwent CTA for nonaortic pathology were selected for comparison. Vitrea Software was used to measure aortic wall thickness, wall irregularity (ulcer, plaque, flaps, and wall calcification), maximum aortic diameter, and intraluminal calcium (Fig) at the aortic arch, descending aorta, and infrarenal aorta.
Results: There were 19 patients identified with >5-year follow-up imaging without repair, and 19 control patients were selected with comparable distribution of sex (P ¼ .1), age (P ¼ .4), and comorbidities (P > .05). The dissection group did have a higher incidence of renal insufficiency than controls (47.4% vs 10.5%; P ¼ .03). The reason for imaging in the control group included evaluation of chest pain (5.4%), aneurysm screening (36.8%), peripheral vascular disease (10.5%), renal/mesenteric arteries (10.5%), and liver and gallbladder pathology (36.8%). Dissection extension beyond the thoracic aorta was noted in 14 of 19 AD patients. This included dissections in the abdominal aorta (68.4%), iliac arteries (63.2%), mesenteric arteries (15.8%), and renal arteries (5.3%). Patients with AD had increased thickening of the aorta at all levels: aortic arch (5.4 mm vs 2.0 mm; P < .001), descending thoracic aorta (8.1 mm vs 2.6 mm; P < .001), and infrarenal abdominal aorta (3.1 mm vs 
